UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Under-reporting of adverse drug reactions : A systematic review

Drug safety, 2006-01, Vol.29 (5), p.385-396

2006

Volltextzugriff (PDF)

Pharmacovigilance study of alendronate in England

Osteoporosis international, 2003-07, Vol.14 (6), p.507-514

2003

Volltextzugriff (PDF)

Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin

British journal of clinical pharmacology, 2005-07, Vol.60 (1), p.98-102

2005

Volltextzugriff (PDF)

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

British journal of rheumatology, 2003-11, Vol.42 (11), p.1354-1364

2003

Volltextzugriff (PDF)

Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England

Osteoporosis international, 2005-12, Vol.16 (12), p.1989-1998

2005

Volltextzugriff (PDF)

Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data

British journal of rheumatology, 2003-11, Vol.42 (11), p.1342-1353

2003

Volltextzugriff (PDF)

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

Journal of psychopharmacology (Oxford), 2001-12, Vol.15 (4), p.265-271

2001

Volltextzugriff (PDF)

First Conference on Big Data for Pharmacovigilance

Drug safety, 2018-12, Vol.41 (12), p.1281-1284

2018

Volltextzugriff (PDF)

Safety profile of oxcarbazepine: Results from a prescription‐event monitoring study

Epilepsia (Copenhagen), 2010-05, Vol.51 (5), p.818-829

2010

Volltextzugriff (PDF)

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

BMJ (Online), 2001-03, Vol.322 (7287), p.651-652

International edition, 2001

Volltextzugriff (PDF)

Utilization of fentanyl buccal tablets in England: Exploring off-label use reported in a cohort study

European journal of pain, 2014-04, Vol.18 (4), p.506-512

2014

Volltextzugriff (PDF)

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets

Drug safety, 2006-01, Vol.29 (2), p.175-181

2006

Volltextzugriff (PDF)

Serious skin reactions and selective COX-2 inhibitors : A case series from prescription-event monitoring in England

Drug safety, 2006-01, Vol.29 (8), p.687-696

2006

Volltextzugriff (PDF)

Prescription-event monitoring and reporting of adverse drug reactions

The Lancet (British edition), 2001-12, Vol.358 (9296), p.1872-1873

2001

Volltextzugriff (PDF)

Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users: A Cohort Study Using Pharmacy Dispensing Data in The Netherlands

Drug safety, 2008-01, Vol.31 (2), p.143-158

2008

Volltextzugriff (PDF)

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

Journal of psychopharmacology (Oxford), 2005-09, Vol.19 (5), p.473-482

2005

Volltextzugriff (PDF)

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: Experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database

Drug safety, 2001, Vol.24 (15), p.1143-1154

2001

Volltextzugriff (PDF)

Causal association in pharmacovigilance and pharmacoepidemiology: Thoughts on the application of the Austin Bradford-Hill criteria

Drug safety, 2002, Vol.25 (6), p.467-471

2002

Volltextzugriff (PDF)

Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

European journal of clinical pharmacology, 2003-12, Vol.59 (10), p.767-773

2003

Volltextzugriff (PDF)

Ron Mann's scientific contributions as the second Director of the DSRU: RON MANN'S SCIENTIFIC CONTRIBUTIONS

Pharmacoepidemiology and drug safety, 2010-08, Vol.19 (8), p.776-777

2010

Volltextzugriff (PDF)

Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology

Drug safety, 2004-01, Vol.27 (7), p.427-456

2004

Volltextzugriff (PDF)

Bill Inman: a drug safety physician and pharmacoepidemiologist

Pharmacoepidemiology and drug safety, 2006-04, Vol.15 (4), p.279-280

Shakir, Saad A.W.

2006

Volltextzugriff (PDF)

Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999

BJU international, 2004-04, Vol.93 (6), p.796-801

2004

Volltextzugriff (PDF)

Ron Mann's scientific contributions as the second Director of the DSRU

Pharmacoepidemiology and drug safety, 2010-08, Vol.19 (8), p.776-777

2010

Volltextzugriff (PDF)

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding ? Results from a cohort study based on prescription event monitoring in England

European journal of clinical pharmacology, 2001-05, Vol.57 (2), p.167-176

2001

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Humans
(48)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Pharmacology & Pharmacy
(35)
Male
(34)
Female
(32)
Pharmacology. Drug Treatments
(31)
Middle Aged
(30)
Aged
(26)
Cohort Studies
(23)
Adult
(22)
Drug Toxicity And Drugs Side Effects Treatment
(22)
England
(20)
Aged, 80 And Over
(18)
Public, Environmental & Occupational Health
(18)
Adverse Drug Reaction Reporting Systems
(13)
Incidence
(13)
Prescription-Event Monitoring
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Under-reporting of adverse drug reactions : A systematic review

Pharmacovigilance study of alendronate in England

Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England

Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

First Conference on Big Data for Pharmacovigilance

Safety profile of oxcarbazepine: Results from a prescription‐event monitoring study

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

Utilization of fentanyl buccal tablets in England: Exploring off-label use reported in a cohort study

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets

Serious skin reactions and selective COX-2 inhibitors : A case series from prescription-event monitoring in England

Prescription-event monitoring and reporting of adverse drug reactions

Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users: A Cohort Study Using Pharmacy Dispensing Data in The Netherlands

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: Experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database

Causal association in pharmacovigilance and pharmacoepidemiology: Thoughts on the application of the Austin Bradford-Hill criteria

Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

Ron Mann's scientific contributions as the second Director of the DSRU: RON MANN'S SCIENTIFIC CONTRIBUTIONS

Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology

Bill Inman: a drug safety physician and pharmacoepidemiologist

Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999

Ron Mann's scientific contributions as the second Director of the DSRU

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding ? Results from a cohort study based on prescription event monitoring in England

Suchergebnisse filtern